202 related articles for article (PubMed ID: 33163928)
21. Complete response of renal cell carcinoma with an inferior vena cava tumor thrombus and lung metastases after treatment with nivolumab plus ipilimumab.
Okada T; Hamamoto S; Etani T; Naiki T; Sue Y; Banno R; Yamada K; Sakakura T; Yasui T
Int Cancer Conf J; 2020 Apr; 9(2):88-91. PubMed ID: 32257760
[TBL] [Abstract][Full Text] [Related]
22. Complete response of metastatic papillary renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus cabozantinib.
Hayashida M; Miura Y; Yamaguchi T; Tanaka M; Yamanaka T; Takemura K; Oka S; Sakaguchi K; Ito S; Urakami S
IJU Case Rep; 2023 Nov; 6(6):419-423. PubMed ID: 37928303
[TBL] [Abstract][Full Text] [Related]
23. Complete remission of renal cell carcinoma with lung carcinomatous lymphangiosis after primary therapy with immune checkpoint inhibitors followed by partial nephrectomy for surgical consolidation.
Kambe T; Yamasaki T; Mine Y; Hagimoto H; Kokubun H; Kubota M; Tsutsumi N; Inoue K; Hara S; Kawakita M
IJU Case Rep; 2022 May; 5(3):168-171. PubMed ID: 35509785
[TBL] [Abstract][Full Text] [Related]
24. Two cases of nivolumab plus ipilimumab therapy for dialysis patients with advanced bone metastasis from renal cell carcinoma.
Takahashi M; Takishita M; Yamazato Y; Kakinoki H; Udo K; Tobu S; Noguchi M
CEN Case Rep; 2023 May; 12(2):237-241. PubMed ID: 36402939
[TBL] [Abstract][Full Text] [Related]
25. Nivolumab efficacy in leptomeningeal metastasis of renal cell carcinoma: a case report.
Bonomi L; Bettini AC; Arnoldi E; Chirco A; Ghilardi L; Manara O; Roscigno M; Da Pozzo LF; Tondini CA
Tumori; 2020 Dec; 106(6):NP76-NP78. PubMed ID: 32041500
[TBL] [Abstract][Full Text] [Related]
26. [A CASE OF UNRESECTABLE METASTATIC RENAL CARCINOMA SUCCESSFULLY TREATED BY COMBINED MODALITY THERAPY WITH NIVOLUMAB AND SURGERY].
Ohmori N; Oki T; Tahara H
Nihon Hinyokika Gakkai Zasshi; 2021; 112(2):105-108. PubMed ID: 35444078
[TBL] [Abstract][Full Text] [Related]
27. Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment.
Tada K; Daizumoto K; Takahashi M; Uehara H; Tsuda M; Kusuhara Y; Fukawa T; Yamamoto Y; Yamaguchi K; Kanayama HO
IJU Case Rep; 2023 Jan; 6(1):41-44. PubMed ID: 36605682
[TBL] [Abstract][Full Text] [Related]
28. Vitiligo-like Depigmentation in a Patient Undergoing Treatment with Nivolumab for Advanced Renal-cell Carcinoma.
Navarro-Fernandez I; Gonzalez-Vela C; Gomez-Fernandez C; Duran-Vian C; Reguero L; Gonzalez-Lopez M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):54-55. PubMed ID: 34477066
[TBL] [Abstract][Full Text] [Related]
29. Effect of rechallenge nivolumab in a hemodialysis patient with multiple metastases from a rapidly progressed T1a renal clear cell carcinoma: An autopsy case.
Hanawa K; Sawada N; Yokota Y; Aikawa J; Otake Y; Sugimura K; Shimura H; Mochizuki T; Kira S; Mitsui T
IJU Case Rep; 2024 May; 7(3):202-205. PubMed ID: 38686062
[TBL] [Abstract][Full Text] [Related]
30. [METASTATIC Mucinous Tubular and Spindle Cell Carcinoma Treated with Nivolumab Successfully : A Case Report].
Takahashi Y; Numakura K; Aoyama Y; Okada S; Saito T; Muto Y; Koizumi A; Nara T; Chiba S; Kanda S; Saito M; Narita S; Inoue T; Satoh S; Nanjo H; Habuchi T
Hinyokika Kiyo; 2019 Sep; 65(9):363-367. PubMed ID: 31697878
[TBL] [Abstract][Full Text] [Related]
31. Case report: Complete remission of bone metastasis from renal cell carcinoma in histopathological examination after treatment with immune checkpoint inhibitors.
Asano Y; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Higuchi T; Taniguchi Y; Morinaga S; Horimoto T; Nakai M; Kadono Y; Nojima T; Tsuchiya H
Front Immunol; 2022; 13():980456. PubMed ID: 36238308
[TBL] [Abstract][Full Text] [Related]
32. Three Cases of Nivolumab Plus Ipilimumab Therapy in Haemodialysis Patients With Metastatic Renal Cell Carcinoma.
Kobari Y; Yoshida K; Iizuka J; Kondo T; Ishida H; Tanabe K; Takagi T
In Vivo; 2021; 35(6):3585-3589. PubMed ID: 34697199
[TBL] [Abstract][Full Text] [Related]
33. [Bilateral adrenal masses from renal cell carcinoma: a case report].
Shioi K; Muraoka K; Tomoda T; Yoshida M; Takase K; Kishi H; Noguchi S
Hinyokika Kiyo; 2006 Jan; 52(1):19-21. PubMed ID: 16479984
[TBL] [Abstract][Full Text] [Related]
34. Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma.
Shirotake S; Miyama YU; Baba Y; Tajima H; Okada Y; Nakazawa K; Usami Y; Yasuda M; Igarashi D; Kaneko GO; Kanao K; Oyama M; Nishimoto K
Anticancer Res; 2022 May; 42(5):2727-2735. PubMed ID: 35489743
[TBL] [Abstract][Full Text] [Related]
35. Metastasis of renal cell carcinoma to the thyroid gland 9 years after nephrectomy: A case report and literature review.
Bayraktar Z; Albayrak S
Arch Ital Urol Androl; 2017 Jun; 89(2):151-153. PubMed ID: 28679190
[TBL] [Abstract][Full Text] [Related]
36. Retroperitoneoscopic partial adrenalectomy for metachronous renal cell carcinoma metastasis to solitary adrenal gland.
Kaneko G; Katsui M; Orikasa H; Hattori S; Hara S
Int Cancer Conf J; 2020 Jan; 9(1):1-4. PubMed ID: 31950008
[TBL] [Abstract][Full Text] [Related]
37. Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report.
Miyauchi Y; Naito H; Tsunemori H; Tani R; Hasui Y; Miyake Y; Minamino T; Ishikawa R; Kushida Y; Haba R; Sugimoto M
J Med Case Rep; 2021 Oct; 15(1):508. PubMed ID: 34649593
[TBL] [Abstract][Full Text] [Related]
38. Case of complete response to neoadjuvant therapy using nivolumab in a patient with metastatic renal cell carcinoma.
Ikarashi D; Kato Y; Katagiri H; Takahara T; Uesugi N; Shiomi E; Sugimura J; Nitta H; Sugai T; Obara W
Int J Urol; 2018 Jun; 25(6):630-632. PubMed ID: 29693280
[TBL] [Abstract][Full Text] [Related]
39. Transperitoneal Laparoscopic Adrenalectomy for Metachronous Contralateral Adrenal Metastasis from Oligometastatic Renal Cell Cancer: Case Report and Review of the Literature.
Öğreden E; Oguz U; Demirelli E; Sabri Tok D; Akyol S; Öksüz H; Aslan S
Curr Med Imaging; 2023 Oct; ():. PubMed ID: 37904565
[TBL] [Abstract][Full Text] [Related]
40. [DEFERRED NEPHRECTOMY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA AFTER A NEAR-COMPLETE RESPONSE TO IMMUNOTHERAPY].
Purim O; Raz O; Eisner A; Baram N; Leonov Polak M; Rybo L
Harefuah; 2022 Dec; 161(12):763-768. PubMed ID: 36916116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
